Insiders Theraclion

Equities

ALTHE

FR0010120402

Market Closed - Euronext Paris Other stock markets 07:45:36 2024-05-16 EDT			5-day change	1st Jan Change
0.498 ^EUR	+0.81%		+13.18%	+28.35%

03-27	Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Theraclion Names CEO	23-05-26	MT
Theraclion Appoints Martin Deterre as CEO	23-05-25	CI
France's Theraclion Appoints New Chairman	22-01-24	MT
Yann Duchesne Appoints New Executive Chairman to Lead Major Shift in Theraclion’s Strategy	22-01-24	CI
Theraclion Appoints Mehdi El Glaoui to Its Board of Directors	21-06-22	CI
Theraclion SA Announces Executive Changes	20-04-28	CI
Theraclion : Christopher S. Bödtker appointed Chairman of Theraclion	20-04-28	BU
Theraclion announces the reinforcement of its Board of Directors with the nomination of a new Non-Executive Director: Mister Renaud Saleur	18-02-07	BU
Mister Renaud Saleur Joins Theraclion to its Board of Directors on February 1, 2018	18-02-07	CI
Theraclion Appoints Laurence Aucoin as Vice President Operations	16-06-16	CI
Theraclion, S.A.S. Announces Board Changes	16-05-18	CI
Theraclion Hires Dennis Guo as Business Development Director for Asia	15-04-15	CI
Theraclion Appoints Michael Leach as Vice-President UK & Northern Europe	14-12-15	CI
THERACLION Announces Executive Changes	14-11-24	CI
Theraclion, S.A.S. Announces Management Changes	14-09-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW